| ID Source | ID |
|---|---|
| PubMed CID | 66628 |
| CHEMBL ID | 2000672 |
| SCHEMBL ID | 69939 |
| MeSH ID | M000613364 |
| Synonym |
|---|
| pyrazine-2,3-dicarboxylic acid |
| 89-01-0 |
| pyrazine-2,3-dicarboxylate |
| 2,3-pyrazinedicarboxylic acid , |
| nsc1908 |
| nsc-1908 |
| NCI60_001592 |
| brn 0147982 |
| 2,3-dicarboxypyrazine |
| nsc 1908 |
| einecs 201-875-3 |
| 2,3-pyrazinedicarboxylic acid, 97% |
| MAYBRIDGE1_001780 |
| SR-01000635503-1 |
| P-8100 |
| AC-1922 |
| HMS546I20 |
| P0545 |
| AKOS000121437 |
| STK711154 |
| 5-25-05-00383 (beilstein handbook reference) |
| unii-qnn35wof29 |
| qnn35wof29 , |
| BBL010075 |
| CCG-45753 |
| 2,3-pyrazinedicarboxylicacid |
| FT-0609763 |
| AM1214 |
| SCHEMBL69939 |
| AB01141154-03 |
| 2,3-pyrazinedicarboxylic acid [mi] |
| pyrazine-2,3- dicarboxylic acid |
| pyrazine-2,3-dicaroxylic acid |
| CHEMBL2000672 |
| BTB 07953 |
| STR06323 |
| 2,3-pyrazine dicarboxylic acid |
| PS-8732 |
| mfcd00006131 |
| J-511414 |
| DTXSID70237467 |
| P19771 |
| SY008112 |
| NCGC00336204-01 |
| EN300-21148 |
| Q27287370 |
| 2,3-pyrazine-dicarboxylic acid |
| pyrazine-2,3-dicarboxylicacid |
| CS-W017821 |
| HY-W017105 |
| Z104492896 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
| AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (26.16) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||